Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P32 Brachytherapy with Chemoradiation for Pancreatic Cancer
NCT00079365Phase 2Unknown
- Sponsor
- University of South Florida
- Start
- May 2001
- Modality
- Radiopharmaceutical
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of chromic phosphate in pancreatic adenocarcinoma (PDAC) (2 arms), sponsored by University of South Florida. Primary endpoint: Overall Survival. Status: unknown.
02
Drugs
chromic phosphate
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00079365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079365.